Melphalan Flufenamide Hydrochloride Patent Expiration
Melphalan Flufenamide Hydrochloride is used for treating relapsed or refractory multiple myeloma in adults who have received at least 4 prior lines of therapy. It was first introduced by Oncopeptides Ab
Melphalan Flufenamide Hydrochloride Patents
Given below is the list of patents protecting Melphalan Flufenamide Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pepaxto | US10285946 | Lyophilized preparations of melphalan flufenamide | Apr 25, 2032 | Oncopeptides Ab |
| Pepaxto | US10322182 | Lyophilized preparation of cytotoxic dipeptides | Apr 25, 2032 | Oncopeptides Ab |
| Pepaxto | US10543274 | Lyophilized preparation of cytotoxic dipeptides | Apr 25, 2032 | Oncopeptides Ab |
| Pepaxto | US10869928 | Lyophilized preparation of cytotoxic dipeptides | Apr 25, 2032 | Oncopeptides Ab |
| Pepaxto | US11344622 | Lyophilized preparation of cytotoxic dipeptides | Apr 25, 2032 | Oncopeptides Ab |
| Pepaxto | US6992207 | Melphalan derivatives and their use as cancer chemotherapeutic drugs |
Jun 25, 2024
(Expired) | Oncopeptides Ab |
Melphalan Flufenamide Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List